跳至主要内容
临床试验/NCT02719119
NCT02719119Unknown不适用

Trial of Monthly Versus Bi-weekly Endoscopic Variceal Ligation for the Prevention of Esophageal Variceal Rebleeding

West China Hospital1 个研究点 分布在 1 个国家目标入组 60 人开始时间: 2016年3月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
入组人数
60
试验地点
1
主要终点
variceal rebleeding rate

研究概览

简要总结

Many physicians suggest repeating EVL every 1-2 weeks until esophageal varices are obliterated to prevent variceal rebleeding, however, the evidences supporting the efficacy of EVL intervals of 1-2 weeks are insufficient.This randomized controlled study was conducted in order to compare the long-term results of EVL when performed at two different results from monthly and bi-weekly treatments.

详细描述

Endoscopic variceal ligation (EVL) is a safe and simple procedure now being used on a widening scale. A lot of patients who undergo endoscopic treatment for esophageal varices eventually require additional treatment for recurrent varices. Many physicians suggest repeating EVL every 1-2 weeks until esophageal varices are obliterated to prevent variceal rebleeding, however, the evidences supporting the efficacy of EVL intervals of 1-2 weeks are insufficient.This randomized controlled study was conducted in order to compare the long-term results of EVL when performed at two different results from monthly and bi-weekly treatments.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 80 Years(Adult, Older Adult)
性别
All
接受健康志愿者
否

入选标准

  • •acute or recent bleeding from esophageal varices;
  • •portal hypertension caused by cirrhosis;
  • •age between 18 and 80 yr.

排除标准

  • •history of endoscopic, pharmacological, interventional or surgical treatment of esophageal varices;
  • •presence of liver failure with a serum total bilirubin concentration greater than 3 mg/dL;
  • •presence of hepatocellular carcinoma or other malignancy;
  • •an association with a cerebral vascular accident, uremia, acute coronary syndrome, or other severe illness;
  • •history of gastric variceal bleeding;
  • •encephalopathy of stage II or worse;
  • •failure to control initial variceal bleeding;
  • •death within 48 h of admission;
  • •refusal to participate in the trial.

研究组 & 干预措施

monthly EVL

Experimental

Elective band ligation was applied after premedication with hyoscine-N-butylbromide (20 mg intramuscularly). A multiband ligator and video endoscopes were utilized. Ligation was initiated at or slightly below the bleeding point. During each treatment session, each varix was ligated with one or two elastic bands. Variceal obliteration success was when all varices disappeared or residual varices were too small to be ligated further. Once esophageal varices were obliterated, surveillance endoscopy was performed every 3 months for 1 year and then every 6 months to check for recurrent varices. Patients in this group will underwent endoscopic variceal ligation monthly.

干预措施: monthly Endoscopic Variceal Ligation (EVL) (Procedure)

bi-weekly EVL

Experimental

Elective band ligation was applied after premedication with hyoscine-N-butylbromide (20 mg intramuscularly). A multiband ligator and video endoscopes were utilized. Ligation was initiated at or slightly below the bleeding point. During each treatment session, each varix was ligated with one or two elastic bands. Variceal obliteration success was when all varices disappeared or residual varices were too small to be ligated further. Once esophageal varices were obliterated, surveillance endoscopy was performed every 3 months for 1 year and then every 6 months to check for recurrent varices. Patients in this group will underwent endoscopic variceal ligation bi-weekly.

干预措施: bi-weekly Endoscopic Variceal Ligation (EVL) (Procedure)

结局指标

主要结局

variceal rebleeding rate

时间窗: 2 years

次要结局

  • number of sessions required to abstain variceal obliteration(2 years)
  • gastrointestinal rebleeding rate(2 years)
  • variceal obliteration rate(2 years)
  • adverse events(2 years)
  • mortality(2 years)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

luo xuefeng

MD

West China Hospital

研究点 (1)

Loading locations...

相似试验